1. Home
  2. CNDT vs NKTX Comparison

CNDT vs NKTX Comparison

Compare CNDT & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Conduent Incorporated

CNDT

Conduent Incorporated

HOLD

Current Price

$1.38

Market Cap

232.4M

ML Signal

HOLD

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.67

Market Cap

227.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNDT
NKTX
Founded
2016
2015
Country
United States
United States
Employees
51000
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
232.4M
227.4M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
CNDT
NKTX
Price
$1.38
$2.67
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$11.33
AVG Volume (30 Days)
1.1M
1.1M
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
11.88
EPS
N/A
N/A
Revenue
$3,042,000,000.00
N/A
Revenue This Year
$2.01
N/A
Revenue Next Year
$4.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.15
$1.63
52 Week High
$2.98
$3.65

Technical Indicators

Market Signals
Indicator
CNDT
NKTX
Relative Strength Index (RSI) 35.94 44.32
Support Level $1.33 $2.59
Resistance Level $1.60 $2.78
Average True Range (ATR) 0.12 0.22
MACD -0.05 -0.05
Stochastic Oscillator 10.37 12.42

Price Performance

Historical Comparison
CNDT
NKTX

About CNDT Conduent Incorporated

Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: